Exhibit 10.1
Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. Double asterisks denote omissions.
CONSULTING AGREEMENT
THIS CONSULTING AGREEMENT (the “Agreement”) is entered into as of April 6, 2022 by and among Epizyme, Inc. (the “Company”), BioStrategy, LLC, a Massachusetts limited liability company (“Consultant”), and Shefali Agarwal (“Dr. Agarwal” or “you”).
WHEREAS, Dr. Agarwal is the sole member of Consultant and has delivered to the Company her resignation from her position as Executive Vice President, Chief Medical and Development Officer of the Company, effective April 6, 2022 (the “Resignation Date”);
WHEREAS, the Company desires to engage Consultant as a consultant to provide consulting services to and for the Company following the effectiveness of Dr. Agarwal’s resignation; and
WHEREAS, Consultant has agreed to provide such services pursuant to the terms and conditions set forth in this Agreement.
NOW, THEREFORE in consideration of the mutual covenants and promises contained herein, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged by the parties hereto, the parties agree as follows:
2
3
6.1 Proprietary Information.
4
6.2 Inventions.
5
6
7
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date and year first above written.
EPIZYME, INC.
By: _/s/ Grant Bogle___________________
Name: Grant Bogle
Title: President and Chief Executive Officer
BIOSTRATEGY, LLC
/s/ Shefali Agarwal____________________
Name: Shefali Agarwal
Title: Member
SHEFALI AGARWAL
/s/Shefali Agarwal____________________
IF " DOCVARIABLE "SWDocIDLocation" 4096" = "1" " DOCPROPERTY "SWDocID" ActiveUS 195632917v.1" ""
EXHIBIT A
RELEASE OF CLAIMS
9
IF " DOCVARIABLE "SWDocIDLocation" 4096" = "1" " DOCPROPERTY "SWDocID" ActiveUS 195632917v.1" ""
10
IF " DOCVARIABLE "SWDocIDLocation" 4096" = "1" " DOCPROPERTY "SWDocID" ActiveUS 195632917v.1" ""
11
IF " DOCVARIABLE "SWDocIDLocation" 4096" = "1" " DOCPROPERTY "SWDocID" ActiveUS 195632917v.1" ""
[remainder of page intentionally omitted]
12
IF " DOCVARIABLE "SWDocIDLocation" 4096" = "1" " DOCPROPERTY "SWDocID" ActiveUS 195632917v.1" ""
IN WITNESS WHEREOF, the parties, intending to be legally bound, have executed this Release of Claims on the date(s) indicated below.
EPIZYME, INC.
/s/ Grant Bogle___________ 06 April 2022__________________________
Date
TO BE SIGNED ON OR BEFORE April 14, 2022.
I hereby agree to the terms and conditions set forth above. I have been given at least twenty-one (21) days to consider this Release of Claims and I have chosen to execute this on the date below. I intend that this Release of Claims will become a binding agreement between me and the Company if I do not revoke my acceptance in writing to Grant Bogle, the Company’s Chief Executive Officer within seven (7) days.
/s/ Shefali Agarwal________ _06 April 2022_______________________
Shefali Agarwal Date
13
IF " DOCVARIABLE "SWDocIDLocation" 4096" = "1" " DOCPROPERTY "SWDocID" ActiveUS 195632917v.1" ""